RNA-blocking Nanotherapy for Ovarian Cancer Boosts Chemotherapy Response in Mice

RNA-blocking Nanotherapy for Ovarian Cancer Boosts Chemotherapy Response in Mice
A lucky circumstance led scientists, working in mice, to discover that nanoparticle-delivered siRNA blockers of a molecule found in ovarian cancer can dramatically improve response to chemotherapy. The siRNA molecules blocked the production of EGFR (epidermal growth factor receptor), which is linked to particularly aggressive cancers. The study, “Targeted in vivo delivery of EGFR siRNA

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , , .

Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

Leave a Comment

Your email address will not be published. Required fields are marked *